1. Field of the Invention
The present invention relates to the purification of 2-difluoromethoxy-1,1,1,2-tetrafluoroethane (desflurane), which is a well known inhalation anesthetic.
2. Description of Related Art
U.S. Provisional Application No. 60/643,301 describes a process for the preparation of desflurane by reaction of 2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane (isoflurane) with hydrogen fluoride (HF) over a fixed bed catalysts. This process has a number of advantages in that it is greener than previous processes, highly efficient and adaptable to a continuous process.
Even though this process also yields desflurane of a purity well within the specifications for anesthetic grade desflurane, the product contains a very small amount of 2,2-dichloro-1,1,1-trifluoroethane (R-123) as a by-product. Since R-123 and desflurane have similar boiling points (27° C. ) and 23° C., respectively) it is not easy to separate the R-123 from the desflurane by distillation.
Nevertheless, the ability to remove the R-123 would afford an even purer product. Accordingly, we have endeavored to reduce the R-123 content in the desflurane product.
This and other objects were met with the present invention, which in a first embodiment relates to a process comprising the following steps:
The present invention relates in a second embodiment to said second mixture comprising desflurane, R-123 and said added water.
The present invention also relates in a third embodiment to said purer desflurane product obtainable as a result of the inventive process.
The first mixture comprising desflurane and R-123 is obtainable from any suitable source and in any suitable manner. In a preferred embodiment, the mixture of desflurane and R-123 already meets the specifications for anesthetic grade desflurane, i.e., the amount of R-123 is sufficiently small that the overall desflurane product meets anesthetic grade desflurane specifications. In a particularly preferred embodiment, the amount of R-123 is 1% by weight or less based on the total weight of the first mixture. In an especially preferred embodiment, the first mixture is prepared by the process described in U.S. Provisional Application Ser. No. 60/643,301, the entire contents of which are hereby incorporated herein by reference. All embodiments described therein are suitable, and are considered described herein as methods for preparing the first mixture.
The amount of water added to form the second mixture can be varied over a relatively wide range. Preferably, the amount of water is 1 to 100% by weight based on the total weight of the first mixture. Especially preferred are embodiments wherein the amount of water is 3 to 15% by weight based on the total weight of the first mixture.
The distillation of the second mixture can be carried out according to techniques well known in the art. Pressure is not critical, and the distillation can be carried out at reduced pressure, at atmospheric pressure or at elevated pressure. Preferably, the distillation is carried out at elevated pressure, especially at 5 to 175 psi.
In a preferred embodiment, the purer desflurane product obtainable by the inventive process has less than 200 ppm of R-123 impurity. In a particularly preferred embodiment, the amount of R-123 is less than 40 ppm, and very preferably less than 5 ppm. In an especially preferred embodiment, the amount of R-123 is less than 3 ppm, or less than 2 ppm, or even less than 1 ppm.
The invention will now be described in greater detail with reference to the following non-limiting example:
To 28.5 kg of desflurane obtainable from the process described in Provisional Application Ser. No. 60/643,301 is added 2.5 kg of water. The mixture is then allowed to reflux for duration shown in the following table and both the overhead (O/H) and bottoms (B) samples are obtained and analyzed using GC.
The column is locked off and drained, the material in the pot is distilled and fractions are collected after distilling 4 kg, 12 kg, 16 kg and 22 kg. These fractions are then analyzed using GC. Finally the total amount of material collected is analyzed. The results are shown in the table below.
It should be understood that the preceding detailed description of the invention is merely a detailed description of one preferred embodiment or of a small number of preferred embodiments of the present invention and that numerous changes to the disclosed embodiment(s) can be made in accordance with the disclosure herein without departing from the spirit or scope of the invention. The preceding detailed description of the invention, therefore, is not meant to limit the scope of the invention in any respect.